is semaglutide a sglt2 inhibitor GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Frontiers | Effects of SGLT2

The microbes go to work

(1995) 61:1402S6S

Despite polished branding and celebrity backing, this is a supplement, not a treatment, and results are modest at best

There have been postmarketing reports of acute pancreatitis, though causality remains uncertain

These drugs fall within two categories: human GLP-1 backbone agents (that is, albiglutide, dulaglutide, liraglutide and semaglutide) and exendin-4 backbone agents (that is, exenatide, lixisenatide and tirzepatidethe latter activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors) 1

This breakthrough emphasizes the power of regenerative medicine and the promise of stem cells in tackling chronic diseases that were once considered incurable